Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "diagnostic"

698 News Found

China medical devices market to surpass $42 billion in 2022: GlobalData
News | July 10, 2022

China medical devices market to surpass $42 billion in 2022: GlobalData

Domestic devices are usually preferred over imported medical devices in the national or regional procurement.


NHA announces successful onboarding of 1 lakh+ healthcare facilities
Policy | July 07, 2022

NHA announces successful onboarding of 1 lakh+ healthcare facilities

It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers


Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
News | July 06, 2022

Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance

The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.


Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
Healthcare | July 06, 2022

Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions

The AICVD tool can predict the risk of cardiovascular disease.


ART Fertility Clinics appoints Dr. Somesh Mittal as CEO, India
People | July 05, 2022

ART Fertility Clinics appoints Dr. Somesh Mittal as CEO, India

Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.


Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement
Healthcare | July 05, 2022

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement

Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery


Biosynth Carbosynth expands peptide offering with acquisition of Pepscan
News | July 01, 2022

Biosynth Carbosynth expands peptide offering with acquisition of Pepscan

Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.


NADMED brings first CE-marked NAD+ analysis kit to the market
Medical Device | June 30, 2022

NADMED brings first CE-marked NAD+ analysis kit to the market

NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites


CPC Scientific announces new California peptide API manufacturing facility
News | June 24, 2022

CPC Scientific announces new California peptide API manufacturing facility

The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity